(19)
(11) EP 3 634 388 A2

(12)

(88) Date of publication A3:
11.04.2019

(43) Date of publication:
15.04.2020 Bulletin 2020/16

(21) Application number: 18811675.0

(22) Date of filing: 10.05.2018
(51) International Patent Classification (IPC): 
A61K 9/48(2006.01)
A61K 9/16(2006.01)
A61K 9/50(2006.01)
A61K 31/4439(2006.01)
(86) International application number:
PCT/TR2018/050221
(87) International publication number:
WO 2019/004980 (03.01.2019 Gazette 2019/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 10.05.2017 TR 201706848
04.05.2018 TR 201806309

(71) Applicant: Sanovel Ilac Sanayi ve Ticaret A.S.
34460 Sariyer/Istanbul (TR)

(72) Inventors:
  • TÜRKYILMAZ, Ali
    34460 Istanbul (TR)
  • PALANTÖKEN, Arzu
    34398Istanbul (TR)
  • URAZ, Ezel
    34445 Istanbul (TR)
  • GÜLKOK, Yildiz
    34460 Istanbul (TR)

(74) Representative: Sevinç, Erkan 
Istanbul Patent A.S. Plaza-33, Büyükdere Cad. No: 33/16 Sisli
34381 Istanbul
34381 Istanbul (TR)

   


(54) SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN ETEXILATE